Publications by Dr Ian Brotherick - ePrints

Browsing publications by Dr Ian Brotherick.

Newcastle Authors	Title	Year
Seb Aspinall Susan Stamp Dr Ian Brotherick Dr Brian Shenton Andrew Griffiths et al.	A method of tumour androgen receptor expression in primary operable breast cancer measured by flow cytometry	2002
Fiona Girdler Dr Ian Brotherick Professor Thomas Lennard Dr James Young Dr Brian Shenton et al.	Changes in the expression of oestrogen receptors (ER alpha and ER beta) in the MCF7 cell line with endocrine treatments	2002
Fiona Girdler Dr Ian Brotherick William Cunliffe Professor Thomas Lennard Dr Brian Shenton et al.	ER alpha and ER alpha exon5 expression in tamoxifen treated tumours	2002
Dr Ian Brotherick Susan Stamp William Cunliffe Dr Gail Higginbottom Dr James Young et al.	Neoadjuvant tamoxifen treatment and its effect on MUC1 expression in primary breast cancer	2002
Seb Aspinall Dr David Cook Dr Ian Brotherick Andrew Griffiths Clive Griffith et al.	Serum adrenal androgens in women with primary operable breast cancer	2002
Seb Aspinall Dr Ian Brotherick Dr David Cook Dr Brian Shenton Andrew Griffiths et al.	Serum testosterone in women with primary operable breast cancer	2002
Dr Ian Brotherick Susan Stamp Fiona Girdler William Cunliffe Professor Thomas Lennard et al.	The influence of tamoxifen treatment on E-cadherin expression in primary breast cancer	2002
Susan Stamp Seb Aspinall Dr Ian Brotherick Dr Brian Shenton Professor Thomas Lennard et al.	The use of multiparameter flow cytometry to quantify the androgen receptor in primary breast cancer	2002
Fiona Girdler Dr Ian Brotherick William Cunliffe Professor Thomas Lennard Dr James Young et al.	Three weeks of tamoxifen treatment alters the expression of ER alpha, ER beta and pS2	2002
Fiona Girdler Dr Ian Brotherick Dr Brian Shenton	ARMS (TM) allele-specific amplification-based detection of mutant p53 DNA and mRNA in tumors of the breast	2001
Fiona Girdler Dr Ian Brotherick Professor Thomas Lennard Dr James Young Dr Brian Shenton et al.	Changes in the expression of oestrogen receptors (ER alpha and ER beta) in the MCF7 cell line with endocrine treatments.	2001
Adillah Binti Yusof Dr Ian Brotherick William Cunliffe Professor Thomas Lennard Dr James Young et al.	ER alpha and ER alpha Delta 5 expression in tamoxifen-treated breast tumours.	2001
Dr Jonathan Hanson Jagnohan Varma Professor Adrian Allen Dr Brian Shenton Dr James Young et al.	MUC1 expression in primary breast cancer: The effect of tamoxifen treatment	2001
Dr Ian Brotherick Fiona Girdler Dr Brian Shenton	The variation in expression of cytokeratin phenotypes in primary breast cancer	2001
Fiona Girdler Dr Ian Brotherick William Cunliffe Professor Thomas Lennard Dr James Young et al.	Three weeks of tamoxifen treatment alters the expression of ER alpha, ER beta and pS2.	2001
Fiona Girdler Dr Brian Shenton Dr James Young Dr Ian Brotherick	Use of the monoclonal antibody DAKO-ERβ (8D5-1) to measure oestrogen receptor beta in breast cancer cells	2001
Fiona Girdler Dr Ian Brotherick	The oestrogen receptors (ERα and ERβ) and their role in breast cancer: A review	2000
Dr Ian Brotherick Dr Brian Shenton Dr Brian Angus Jagnohan Varma Professor Frederick Campbell et al.	Cyclin D3 expression, cell proliferation and pathological stage of human primary colorectal cancer	1999
Dr Daya Karat Dr Ian Brotherick Dr Brian Shenton Dr Debbie Scott Professor Michael Griffin et al.	Expression of oestrogen and progesterone receptors in gastric cancer: a flow cytometric study	1999
Dr Ian Brotherick Dr Brian Shenton Ronald Wilson Professor Frederick Campbell	Growth dysregulation and p53 accumulation in human primary colorectal cancer	1999
Dr David Cook Dr Ian Brotherick Dr Brian Shenton Emeritus Professor Colin Self	Lectin ELISA for the c-erb-B2 tumor marker protein p185 in patients with breast cancer and controls	1999
Garrett Durkan Dr Ian Brotherick Kilian Mellon	The impact of transurethral resection of bladder tumour on serum levels of soluble E-cadherin	1999
Dr Ian Brotherick Professor Craig Robson Dr Jonathan Shenfine Michael White William Cunliffe et al.	Cytokeratin expression in breast cancer: Phenotypic changes associated with disease progression	1998
Dr Ian Brotherick Dr Brian Shenton Professor Thomas Lennard	Are fine needle breast aspirates representative of the underlying solid tumor: a comparison on receptor levels, ploidy and the influence of cytokeratin gates	1995
Dr Ian Brotherick Dr Brian Shenton Dr William Cowan Dr Brian Angus Professor Thomas Lennard et al.	P53 expression measured by flow cytometry: a comparison of 3 monoclonal antibodies and the relationship with grade and DNA ploidy in breast cancer	1995
Dr Ian Brotherick Dr Brian Shenton Dr Brian Angus Ian Waite Professor Thomas Lennard et al.	A flow cytometric study of c-erbB-3 expression in breast cancer	1995
Dr Ian Brotherick Dr Brian Shenton Dr William Cowan Dr Brian Angus Professor Thomas Lennard et al.	Relationship between flow cytometric and immunohistochemically detected C-ERBB-2 expression, grade and DNA ploidy in breast cancer	1995
Dr Ian Brotherick Professor Thomas Lennard Susan Cook Dr Brian Shenton	Use of the biotinylated antibody dako-ER 1D5 to measure estrogen receptor on cytokeratin positive cells obtained from primary breast cancer cells	1995
Dr Ian Brotherick Professor Thomas Lennard Susan Cook Dr Brian Shenton	Flow cytometric method for the measurement of epidermal growth-factor receptor and comparison with the radio-ligand binding assay	1994
Dr Ian Brotherick Dr Brian Shenton Emeritus Professor John Kirby Dr Jeremy Palmer Emeritus Professor Steve Yeaman et al.	Production of immunosuppressive factors by a cultured tumor cell line and their effect on lymphocyte proliferation and cells cycle response	1993
Dr Brian Shenton Dr Ian Brotherick Robert Taylor Professor Thomas Lennard	Alterations in circulating lymphocyte number and function after circulation through colorectal carcinomas	1991